<DOC>
	<DOCNO>NCT00922961</DOCNO>
	<brief_summary>25 patient , treat brachytherapy phase II study `` Mammosite '' ( 2003 2005 ) , ask attend clinical exam order evaluate late cutaneous toxicity due brachytherapy . During consultation , blood sample take analysis ( rate CD8 T-Lymphocyte Apoptosis )</brief_summary>
	<brief_title>Research Predictive Biologic Parameters Cutaneous Hypersensitivity After Brachytherapy Breast Cancer</brief_title>
	<detailed_description>This interventional study french law</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<criteria>All patient treat exclusive peroperative brachytherapy prior study Mammosite breast cancer Patient social security</criteria>
	<gender>Female</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>brachytherapy , late cutaneous toxicity</keyword>
</DOC>